ResearcherMayo ClinicActive in the last 2 years
Priyabrata Mukherjee
Matched on ORCID iD 0000-0002-0557-0833; OpenAlex author ID A5023272117; NIH RePORTER profile ID 8493535. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 0, last author 6)
- Trials
- 0
- Grants
- 6
- Labs led
- 2
- Collaborators
- 25
2011: 1 paper · 2012: none · 2013: 1 paper, 1 grant · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers, 1 grant · 2021: 2 papers, 1 grant · 2022: 2 papers, 1 grant · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper, 2 grants
Papers 12
- Correction to "Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer". Co-author DOI 10.1021/acsami.6c01352↗
- Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic cancer. Last author DOI 10.1016/j.canlet.2024.216810↗
- Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.neo.2023.100951↗
- Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer. Co-author DOI 10.1016/j.actbio.2021.10.048↗
- The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress. Co-author DOI 10.1038/s41698-022-00336-x↗
- Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. Co-author DOI 10.1021/acsami.1c09379↗
- Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer. Co-author DOI 10.1038/s41598-021-83658-3↗
- Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer. Last author DOI 10.1096/fj.201902826rr↗
- Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro. Last author DOI 10.2147/ijn.s234112↗
- Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine. Last author DOI 10.15698/cst2019.08.195↗
- Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics. Last author DOI 10.1371/journal.pone.0057522↗
- Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. Last author DOI 10.1371/journal.pone.0020347↗
Grants 6
- Exploiting gold nanoparticle as a probe to identify therapeutic targets R01CA260449↗
- Protein-nanoparticle interaction to study multicellular crosstalk within ovarian tumor microenviroment R01CA297076↗
- UBAP2, A New Molecule in Pancreatic Cancer Progression R01CA220237↗
- Reprogramming Tumor Microenvironment by Nanoparticle R01CA213278↗
- Molecular Mechanism of Antiangiogenic Properties of Gold Nanoparticle R01CA136494↗
- Development of a gold nanoparticles based targeted delivery system R01CA135011↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Resham Bhattacharya · 7 shared papers, 2 shared grants, 2011–2026 · strength 3.27
- Grant Exploiting gold nanoparticle as a probe to identify therapeutic targets R01CA260449↗
- Grant Protein-nanoparticle interaction to study multicellular crosstalk within ovarian tumor microenviroment R01CA297076↗
- Paper Biodistribution and therapeutic efficacy of a gold nanoparticle-based targeted drug delivery system against pancreatic … DOI 10.1016/j.canlet.2024.216810↗
- William M. MacCuaig · 3 shared papers, 2021–2026 · strength 0.54
- Paper Correction to "Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Or… DOI 10.1021/acsami.6c01352↗
- Paper Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer. DOI 10.1038/s41598-021-83658-3↗
- Paper Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancre… DOI 10.1021/acsami.1c09379↗
- Lacey R. McNally · 3 shared papers, 2021–2026 · strength 0.54
- Paper Correction to "Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Or… DOI 10.1021/acsami.6c01352↗
- Paper Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer. DOI 10.1038/s41598-021-83658-3↗
- Paper Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancre… DOI 10.1021/acsami.1c09379↗
- Chandra Kumar Elechalawar · 2 shared papers, 2020–2024 · strength 0.33
- Upender Manne · 1 shared paper, 2024 · strength 0.20
- Xunhao Xiong · 2 shared papers, 2019–2020 · strength 0.20
- Farrukh Afaq · 1 shared paper, 2024 · strength 0.20
- Sooryanarayana Varambally · 1 shared paper, 2024 · strength 0.20
- Moh'd M. Khushman · 1 shared paper, 2024 · strength 0.20
- Sumit Agarwal · 1 shared paper, 2024 · strength 0.20
- Subhash C. Chauhan · 1 shared paper, 2024 · strength 0.20
- Udayan Bhattacharya · 1 shared paper, 2022 · strength 0.16
- Feifan Zhou · 1 shared paper, 2022 · strength 0.15
- Wei R. Chen · 1 shared paper, 2022 · strength 0.15
- Meng Wang · 1 shared paper, 2022 · strength 0.15
- Maged Henary · 1 shared paper, 2021 · strength 0.13
- Matthew D. Laramie · 1 shared paper, 2021 · strength 0.13
- Yanyan Huai · 1 shared paper, 2019 · strength 0.11
- Danny N. Dhanasekaran · 1 shared paper, 2020 · strength 0.09
- Chinthalapally V. Rao · 1 shared paper, 2020 · strength 0.09
- Jameel Ahmad Khan · 2 shared papers, 2011–2013 · strength 0.06
- Rachel A. Kudgus · 2 shared papers, 2011–2013 · strength 0.06
- Vijay H. Shah · 1 shared paper, 2011 · strength 0.02
- Steven A. Curley · 1 shared paper, 2011 · strength 0.02
- Debabrata Mukhopadhyay · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.